Moderna Reports $966M Q4 2024 Revenue Amid COVID-19 Vaccine Decline, Focuses on mRNA Pipeline Expansion

Financial Performance Overview Moderna reported Q4 2024 revenue of $966 million, marking a 66% decline year-over-year (...

February 17, 2025 | Monday | Company results
GSK Reports Strong Q4 2024 Growth in Specialty Medicines and HIV, Offsetting Vaccine Declines

GSK delivered a strong performance in Q4 2024, with total sales reaching £8.12 billion, reflecting a 4% year-over-...

February 17, 2025 | Monday | Company results
Eli Lilly Reports Record Q4 2024 Revenue of $13.53B, Fueled by Mounjaro, Zepbound, and Oncology Growth

Eli Lilly & Co. reported a strong financial performance in Q4 2024, with substantial revenue growth driven by its bl...

February 17, 2025 | Monday | Company results
Biogen Reports Q4 and Full-Year 2024 Results: Strong EPS Growth Amid Revenue Challenges

Key Financial Highlights Biogen Inc. reported its fourth-quarter (Q4) and full-year 2024 results on February 12, 2025. ...

February 17, 2025 | Monday | Company results
AstraZeneca Reports Strong Q4 2024 Growth with $14.89 Billion Revenue, Driven by Oncology and Innovative Therapies

  AstraZeneca delivered a strong performance in Q4 2024, with Total Revenue reaching $14.89 billion, marking a 24%...

February 17, 2025 | Monday | Company results
Korea's Hanmi Pharma introduces new automated vial dispensing solution in Canada and US

South Korea-based Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significant strides ...

February 15, 2025 | Saturday | News
Qiagen strengthens global bioinformatics leadership with new centre in APAC region

Qiagen has announced the official opening of a new data centre in Melbourne, Australia, designed to strengthen its globa...

February 14, 2025 | Friday | News
Korea's SK bioscience collaborates with WHO to strengthen infectious disease response

South Korea-based SK bioscience has announced that it is the only private company to participate in the World Health Org...

February 12, 2025 | Wednesday | News
Australian startup ENA Respiratory secures $5M to develop nasal powder against viral infections

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimise ...

February 12, 2025 | Wednesday | News
Zydus and Synthon to commercialise novel 505(B)(2) oncology product in US market

India-based Zydus Lifesciences (including its subsidiaries and affiliates), has signed an exclusive development, licensi...

February 12, 2025 | Wednesday | News
Bio X Cell expands global reach with new distribution centre in China

Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its globa...

February 13, 2025 | Thursday | News
Australia's AdvanCell partners with Lilly to develop new targeted alpha therapies for cancer treatment

AdvanCell, a radiopharmaceutical company specialising in targeted alphaherapias, has announced the expansion of the scop...

February 11, 2025 | Tuesday | News
OliX Pharma and Lilly to develop treatment for metabolic-associated steatohepatitis

South Korea-based OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced a global licensing...

February 10, 2025 | Monday | News
Japan's PHC partners with CCRM in Canada to develop primary T-cell expansion culture processes

Japan-based PHC Corporation has signed a Master Collaboration Agreement with CCRM (based in Canada) to work together on ...

February 10, 2025 | Monday | News
Korean firm LG to develop AI model for protein multistate structure prediction

LG AI Research recently signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,&...

February 9, 2025 | Sunday | News
Bain Capital to acquire Mitsubishi Tanabe Pharma Corporation for $3.3 B

Bain Capital, a leading global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe P...

February 6, 2025 | Thursday | News
Dr. Reddy's Lab inks oncology deal of $131 M with Shanghai Henlius Biotech

Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of India-based Dr. Reddy’s Laboratories Ltd. has entere...

February 6, 2025 | Thursday | News
BD announces intent to separate biosciences and diagnostic solutions business

BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in the US, has announ...

February 6, 2025 | Thursday | News
ValGenesis and Hitachi join forces to digitally transform Japan's life sciences sector

US-based ValGenesis Inc., the global leader in enterprise validation lifecycle management systems (VLMS), and Hitachi In...

February 5, 2025 | Wednesday | News
Singapore-based startup Gene Solutions to introduce smart blood test for lung screening in early 2025

Gene Solutions (GS), a pioneer genomic testing company in South-East Asia, aims to introduce a smart blood test to ...

February 5, 2025 | Wednesday | News
MediBuddy partners with Japan's Elecom to launch smart health devices in India

MediBuddy, India's largest digital healthcare company, has announced a strategic partnership with ELECOM, a leading Japa...

February 4, 2025 | Tuesday | News
Alexion Pharmaceuticals Sets New Benchmarks in Rare Disease Innovation and Financial Growth in 2024

  Clinically, Alexion has made substantial strides in the treatment of rare and debilitating conditions. A...

September 4, 2024 | Wednesday | Analysis
Beam Therapeutics Accelerates Progress in Gene-Editing: Major Milestones Achieved in 2024

Beam Therapeutics, a leader in the gene-editing field, continues to make significant progress in its mission to ...

September 4, 2024 | Wednesday | Analysis
Argenx Breaks New Ground in Autoimmune Therapy with 2024 Milestones

Argenx, a global leader in immunology, has made significant strides in 2024, bolstering its position as a pioneer in the...

September 4, 2024 | Wednesday | Analysis
Bluebird Bio Soars: Pioneering Gene Therapies Fuel Rapid Growth in 2024

Bluebird Bio, a pioneering company in the gene therapy sector, has made significant strides in 2024, showcasing both ope...

September 4, 2024 | Wednesday | Analysis